Mount Sinai Health System Partners with Contessa to Create Mount Sinai at Home, a Home-Based Care Continuum
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: GlobeNewswire
NEW YORK and NASHVILLE, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Mount Sinai Health System and Contessa, the leading comprehensive home-based care provider, announced the extension of their partnership combining Mount Sinai South Nassau’s home health agency into their existing joint venture. The new combination offers a full continuum of home-based care that includes home health, hospitalization at home, rehabilitation at home (in lieu of care at a skilled nursing facility) and palliative care at home. The home health agency will be called Mount Sinai at Home. “This new initiative accelerates our strategic goal of delivering a continuum of home-based care to more Mount Sinai patients,” said Aaron Stein, chief operating officer at Contessa. “Mount Sinai at Home provides a strong offering to patients, providers and health plans. Together, we are truly changing healthcare by rendering care where patients want it the most, their homes.” This new entity is the result of a strengthened
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.MarketBeat
- Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]Yahoo! Finance
- Amedisys Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Amedisys Reports First Quarter 2024 Financial ResultsGlobeNewswire
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/25/24 - Form 10-Q
- 4/24/24 - Form 8-K
- AMED's page on the SEC website